Correction to: Dyslipidemia and metabolic syndrome in childhood-onset systemic lupus erythematosus: is it time to screen? (Lipids in Health and Disease, (2024), 23, 1, (406), 10.1186/s12944-024-02395-4)

1Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following publication of the original article [1], the authors requested to update the Methods section. In the methods section regarding the definition of metabolic syndrome on page 3, the sentences currently reads: “Metabolic syndrome” was defined according to International Diabetes Federation criteria, which diagnose patients aged at least 10 years; the definition of metabolic syndrome in children and adolescents age 10 to less than 16 years were obesity ≥ 90th percentile (or adult cutoff if lower) as assessed by waist circumference, TG ≥ 150 mg/dL (1.7 mmol/L), HDL-C < 40 mg/dL (1.03 mmol/L), systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg, FBG ≥ 100 mg/dL (5.6 mmol/L) or known type 2 diabetes mellitus [33]; for age 16 years or older, the adult definition for metabolic syndrome definition were applied consisting of waist circumference ≥ 90 cm for men or ≥ 80 cm for women, plus any two of the following: raised TG > 150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality, reduced HDL-C < 40 mg/dl (1.03 mmol/L) in men or < 50 mg/L (1.29 mmol/L) in women or specific treatment for this lipid abnormality, raised systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or treatment of previously diagnosed hypertension, raised FBG ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 diabetes mellitus [17, 33]. The sentence should read: “Metabolic syndrome” was defined according to International Diabetes Federation criteria, which diagnose patients aged at least 10 years; the definition of metabolic syndrome in children and adolescents age 10 to less than 16 years were obesity ≥ 90th percentile (or adult cutoff if lower) as assessed by waist circumference, plus any two of the following: TG ≥ 150 mg/dL (1.7 mmol/L), HDL-C < 40 mg/dL (1.03 mmol/L), systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg, FBG ≥ 100 mg/dL (5.6 mmol/L) or known type 2 diabetes mellitus [33]; for age 16 years or older, the adult definition for metabolic syndrome definition were applied consisting of waist circumference ≥ 90 cm for men or ≥ 80 cm for women, plus any two of the following: raised TG ≥ 150 mg/dL (1.7 mmol/L) or specific treatment for this lipid abnormality, reduced HDL-C < 40 mg/dl (1.03 mmol/L) in men or < 50 mg/L (1.29 mmol/L) in women or specific treatment for this lipid abnormality, raised systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or treatment of previously diagnosed hypertension, raised FBG ≥ 100 mg/dL (5.6 mmol/L) or previously diagnosed type 2 diabetes mellitus [17, 33]. In the methods section regarding the sample size calculation on page 4, the sentences currently reads: The parameters used were type I error (α) = 0.05, allowable error (e) = 0.0945 (15% of p), Zɑ/2 = Z0.025 = 1.96, and p = 0.63. This calculation resulted in a minimum sample size of 100 participants. Accounting for a 10% dropout rate, the final sample size for this study was determined to be at least 111 participants. The sentence should read. The parameters used were type I error (α) = 0.05, allowable error (e) = 0.07 (12% of p), Zɑ/2 = Z0.025 = 1.96, and p = 0.63. This calculation resulted in a minimum sample size of 182 participants. Accounting for a 10% dropout rate, the final sample size for this study was determined to be 200 participants. The original article [1] has been corrected.

Cite

CITATION STYLE

APA

Nuntasri, S., Charuvanij, S., Lomjansook, K., Saengpanit, P., Chotipanang, K., & Sukharomana, M. (2025, December 1). Correction to: Dyslipidemia and metabolic syndrome in childhood-onset systemic lupus erythematosus: is it time to screen? (Lipids in Health and Disease, (2024), 23, 1, (406), 10.1186/s12944-024-02395-4). Lipids in Health and Disease . BioMed Central Ltd. https://doi.org/10.1186/s12944-025-02453-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free